Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance

  1. Rebecca EK Mandt  Is a corresponding author
  2. Madeline R Luth
  3. Mark A Tye
  4. Ralph Mazitschek
  5. Sabine Ottilie
  6. Elizabeth A Winzeler
  7. Maria Jose Lafuente-Monasterio
  8. Francisco Javier Gamo
  9. Dyann F Wirth
  10. Amanda K Lukens  Is a corresponding author
  1. Harvard T H Chan School of Public Health, United States
  2. University of California, San Diego, United States
  3. Massachusetts General Hospital, United States
  4. GlaxoSmithKline, Spain
  5. Broad Institute, United States

Abstract

Drug resistance remains a major obstacle to malaria control and eradication efforts, necessitating the development of novel therapeutic strategies to treat this disease. Drug combinations based on collateral sensitivity, wherein resistance to one drug causes increased sensitivity to the partner drug, have been proposed as an evolutionary strategy to suppress the emergence of resistance in pathogen populations. In this study, we explore collateral sensitivity between compounds targeting the Plasmodium dihydroorotate dehydrogenase (DHODH). We profiled the cross-resistance and collateral sensitivity phenotypes of several DHODH mutant lines to a diverse panel of DHODH inhibitors. We focus on one compound, TCMDC-125334, which was active against all mutant lines tested, including the DHODH C276Y line, which arose in selections with the clinical candidate DSM265. In six selections with TCMDC-125334, the most common mechanism of resistance to this compound was copy number variation of the dhodh locus, although we did identify one mutation, DHODH I263S, which conferred resistance to TCMDC-125334 but not DSM265. We found that selection of the DHODH C276Y mutant with TCMDC-125334 yielded additional genetic changes in the dhodh locus. These double mutant parasites exhibited decreased sensitivity to TCMDC-125334 and were highly resistant to DSM265. Finally, we tested whether collateral sensitivity could be exploited to suppress the emergence of resistance in the context of combination treatment by exposing wildtype parasites to both DSM265 and TCMDC-125334 simultaneously. This selected for parasites with a DHODH V532A mutation which were cross-resistant to both compounds and were as fit as the wildtype parent in vitro. The emergence of these cross-resistant, evolutionarily fit parasites highlights the mutational flexibility of the DHODH enzyme.

Data availability

The raw whole-genome sequencing data generated in this study have been submitted to the NCBI Sequence Read Archive database (https://www.ncbi.nlm.nih.gov/sra/) under accession number PRJNA689594. Sanger sequencing of the PCR amplified dhodh locus have been submitted to GenBank (NCBI) under accession numbers MZ571149-MZ571158.

The following data sets were generated

Article and author information

Author details

  1. Rebecca EK Mandt

    Harvard T H Chan School of Public Health, Boston, United States
    For correspondence
    rebeccamandt@gmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7165-7876
  2. Madeline R Luth

    University of California, San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  3. Mark A Tye

    Massachusetts General Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  4. Ralph Mazitschek

    Massachusetts General Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  5. Sabine Ottilie

    University of California, San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  6. Elizabeth A Winzeler

    University of California, San Diego, San Diego, United States
    Competing interests
    Elizabeth A Winzeler, Sits on the advisory board of the Tres Cantos Open Lab Foundation.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4049-2113
  7. Maria Jose Lafuente-Monasterio

    GlaxoSmithKline, Tres Cantos, Spain
    Competing interests
    Maria Jose Lafuente-Monasterio, GlaxoSmithKline employee.
  8. Francisco Javier Gamo

    GlaxoSmithKline, Tres Cantos, Spain
    Competing interests
    Francisco Javier Gamo, GlaxoSmithKline employee.
  9. Dyann F Wirth

    Harvard T H Chan School of Public Health, Boston, United States
    Competing interests
    Dyann F Wirth, Sits on the advisory board of Medicines for Malaria Venture.
  10. Amanda K Lukens

    Broad Institute, Cambridge, United States
    For correspondence
    alukens@broadinstitute.org
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9560-7643

Funding

National Institutes of Health (R01 AI093716)

  • Rebecca EK Mandt
  • Dyann F Wirth
  • Amanda K Lukens

Bill and Melinda Gates Foundation (OPP1132451)

  • Rebecca EK Mandt
  • Maria Jose Lafuente-Monasterio
  • Francisco Javier Gamo
  • Dyann F Wirth
  • Amanda K Lukens

National Institutes of Health (T32 GM008666)

  • Madeline R Luth

ExxonMobil Foundation

  • Rebecca EK Mandt
  • Dyann F Wirth
  • Amanda K Lukens

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Mandt et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 704
    views
  • 150
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rebecca EK Mandt
  2. Madeline R Luth
  3. Mark A Tye
  4. Ralph Mazitschek
  5. Sabine Ottilie
  6. Elizabeth A Winzeler
  7. Maria Jose Lafuente-Monasterio
  8. Francisco Javier Gamo
  9. Dyann F Wirth
  10. Amanda K Lukens
(2023)
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance
eLife 12:e85023.
https://doi.org/10.7554/eLife.85023

Share this article

https://doi.org/10.7554/eLife.85023

Further reading

    1. Evolutionary Biology
    2. Genetics and Genomics
    Giulia Ferraretti, Paolo Abondio ... Marco Sazzini
    Research Article

    It is well established that several Homo sapiens populations experienced admixture with extinct human species during their evolutionary history. Sometimes, such a gene flow could have played a role in modulating their capability to cope with a variety of selective pressures, thus resulting in archaic adaptive introgression events. A paradigmatic example of this evolutionary mechanism is offered by the EPAS1 gene, whose most frequent haplotype in Himalayan highlanders was proved to reduce their susceptibility to chronic mountain sickness and to be introduced in the gene pool of their ancestors by admixture with Denisovans. In this study, we aimed at further expanding the investigation of the impact of archaic introgression on more complex adaptive responses to hypobaric hypoxia evolved by populations of Tibetan/Sherpa ancestry, which have been plausibly mediated by soft selective sweeps and/or polygenic adaptations rather than by hard selective sweeps. For this purpose, we used a combination of composite-likelihood and gene network-based methods to detect adaptive loci in introgressed chromosomal segments from Tibetan WGS data and to shortlist those presenting Denisovan-like derived alleles that participate to the same functional pathways and are absent in populations of African ancestry, which are supposed to do not have experienced Denisovan admixture. According to this approach, we identified multiple genes putatively involved in archaic introgression events and that, especially as regards TBC1D1, RASGRF2, PRKAG2, and KRAS, have plausibly contributed to shape the adaptive modulation of angiogenesis and of certain cardiovascular traits in high-altitude Himalayan peoples. These findings provided unprecedented evidence about the complexity of the adaptive phenotype evolved by these human groups to cope with challenges imposed by hypobaric hypoxia, offering new insights into the tangled interplay of genetic determinants that mediates the physiological adjustments crucial for human adaptation to the high-altitude environment.

    1. Ecology
    2. Evolutionary Biology
    Zhixian Zhang, Jianying Li ... Songdou Zhang
    Research Article

    Seasonal polyphenism enables organisms to adapt to environmental challenges by increasing phenotypic diversity. Cacopsylla chinensis exhibits remarkable seasonal polyphenism, specifically in the form of summer-form and winter-form, which have distinct morphological phenotypes. Previous research has shown that low temperature and the temperature receptor CcTRPM regulate the transition from summer-form to winter-form in C. chinensis by impacting cuticle content and thickness. However, the underling neuroendocrine regulatory mechanism remains largely unknown. Bursicon, also known as the tanning hormone, is responsible for the hardening and darkening of the insect cuticle. In this study, we report for the first time on the novel function of Bursicon and its receptor in the transition from summer-form to winter-form in C. chinensis. Firstly, we identified CcBurs-α and CcBurs-β as two typical subunits of Bursicon in C. chinensis, which were regulated by low temperature (10 °C) and CcTRPM. Subsequently, CcBurs-α and CcBurs-β formed a heterodimer that mediated the transition from summer-form to winter-form by influencing the cuticle chitin contents and cuticle thickness. Furthermore, we demonstrated that CcBurs-R acts as the Bursicon receptor and plays a critical role in the up-stream signaling of the chitin biosynthesis pathway, regulating the transition from summer-form to winter-form. Finally, we discovered that miR-6012 directly targets CcBurs-R, contributing to the regulation of Bursicon signaling in the seasonal polyphenism of C. chinensis. In summary, these findings reveal the novel function of the neuroendocrine regulatory mechanism underlying seasonal polyphenism and provide critical insights into the insect Bursicon and its receptor.